Avail upto 30% off on all reports till July 31st.

Liver Cancer Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Date: Jan 28 2021
|
99Strategy
|
Number of Pages: 93
|
Category: Medical Care

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Liver Cancer Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Liver Cancer Therapeutics market segmented into
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Others

Based on the end-use, the global Liver Cancer Therapeutics market classified into
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Others

Based on geography, the global Liver Cancer Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
ArQule
Bayer
Bristol-Myers Squibb
Celsion
Eisai
Exelixis
Roche
Merck
Pfizer
IntegraGen


Table of Contents
1 RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
           1.2.1 Product Type
           1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL LIVER CANCER THERAPEUTICS INDUSTRY
    2.1 Summary about Liver Cancer Therapeutics Industry
    2.2 Liver Cancer Therapeutics Market Trends
           2.2.1 Liver Cancer Therapeutics Production & Consumption Trends
           2.2.2 Liver Cancer Therapeutics Demand Structure Trends
    2.3 Liver Cancer Therapeutics Cost & Price
3 MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
           3.2.1 Drivers
           3.2.2 Restraints
           3.2.3 Opportunity
           3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
           4.1.1 North America (U.S., Canada and Mexico)
           4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
           4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
           4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
           4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
           4.2.1 Targeted Therapy
           4.2.2 Radiation Therapy
           4.2.3 Immunotherapy
           4.2.4 Chemotherapy
           4.2.5 Others
    4.3 Consumption Segmentation (2017 to 2021f)
           4.3.1 Hepatocellular Carcinoma
           4.3.2 Cholangio Carcinoma
           4.3.3 Hepatoblastoma
           4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
           5.1.1 U.S.
           5.1.2 Canada
           5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
           5.2.1 Targeted Therapy
           5.2.2 Radiation Therapy
           5.2.3 Immunotherapy
           5.2.4 Chemotherapy
           5.2.5 Others
    5.3 Consumption Segmentation (2017 to 2021f)
           5.3.1 Hepatocellular Carcinoma
           5.3.2 Cholangio Carcinoma
           5.3.3 Hepatoblastoma
           5.3.4 Others
    5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
           6.1.1 Germany
           6.1.2 UK
           6.1.3 France
           6.1.4 Italy
           6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
           6.2.1 Targeted Therapy
           6.2.2 Radiation Therapy
           6.2.3 Immunotherapy
           6.2.4 Chemotherapy
           6.2.5 Others
    6.3 Consumption Segmentation (2017 to 2021f)
           6.3.1 Hepatocellular Carcinoma
           6.3.2 Cholangio Carcinoma
           6.3.3 Hepatoblastoma
           6.3.4 Others
    6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
           7.1.1 China
           7.1.2 India
           7.1.3 Japan
           7.1.4 South Korea
           7.1.5 Southeast Asia
           7.1.6 Australia
           7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
           7.2.1 Targeted Therapy
           7.2.2 Radiation Therapy
           7.2.3 Immunotherapy
           7.2.4 Chemotherapy
           7.2.5 Others
    7.3 Consumption Segmentation (2017 to 2021f)
           7.3.1 Hepatocellular Carcinoma
           7.3.2 Cholangio Carcinoma
           7.3.3 Hepatoblastoma
           7.3.4 Others
    7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
           8.1.1 Brazil
           8.1.2 Argentina
           8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
           8.2.1 Targeted Therapy
           8.2.2 Radiation Therapy
           8.2.3 Immunotherapy
           8.2.4 Chemotherapy
           8.2.5 Others
    8.3 Consumption Segmentation (2017 to 2021f)
           8.3.1 Hepatocellular Carcinoma
           8.3.2 Cholangio Carcinoma
           8.3.3 Hepatoblastoma
           8.3.4 Others
    8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
           9.1.1 GCC
           9.1.2 North Africa
           9.1.3 South Africa
           9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
           9.2.1 Targeted Therapy
           9.2.2 Radiation Therapy
           9.2.3 Immunotherapy
           9.2.4 Chemotherapy
           9.2.5 Others
    9.3 Consumption Segmentation (2017 to 2021f)
           9.3.1 Hepatocellular Carcinoma
           9.3.2 Cholangio Carcinoma
           9.3.3 Hepatoblastoma
           9.3.4 Others
    9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
           10.1.1 ArQule
           10.1.2 Bayer
           10.1.3 Bristol-Myers Squibb
           10.1.4 Celsion
           10.1.5 Eisai
           10.1.6 Exelixis
           10.1.7 Roche
           10.1.8 Merck
           10.1.9 Pfizer
           10.1.10 IntegraGen
    10.2 Liver Cancer Therapeutics Sales Date of Major Players (2017-2020e)
           10.2.1 ArQule
           10.2.2 Bayer
           10.2.3 Bristol-Myers Squibb
           10.2.4 Celsion
           10.2.5 Eisai
           10.2.6 Exelixis
           10.2.7 Roche
           10.2.8 Merck
           10.2.9 Pfizer
           10.2.10 IntegraGen
    10.3 Market Distribution of Major Players
    10.4 Global Competition Segmentation
11 MARKET FORECAST
    11.1 Forecast by Region
    11.2 Forecast by Demand
    11.3 Environment Forecast
           11.3.1 Impact of COVID-19
           11.3.2 Geopolitics Overview
           11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Liver Cancer Therapeutics Product Type Overview
2.Table Liver Cancer Therapeutics Product Type Market Share List
3.Table Liver Cancer Therapeutics Product Type of Major Players
4.Table Brief Introduction of ArQule
5.Table Brief Introduction of Bayer
6.Table Brief Introduction of Bristol-Myers Squibb
7.Table Brief Introduction of Celsion
8.Table Brief Introduction of Eisai
9.Table Brief Introduction of Exelixis
10.Table Brief Introduction of Roche
11.Table Brief Introduction of Merck
12.Table Brief Introduction of Pfizer
13.Table Brief Introduction of IntegraGen
14.Table Products & Services of ArQule
15.Table Products & Services of Bayer
16.Table Products & Services of Bristol-Myers Squibb
17.Table Products & Services of Celsion
18.Table Products & Services of Eisai
19.Table Products & Services of Exelixis
20.Table Products & Services of Roche
21.Table Products & Services of Merck
22.Table Products & Services of Pfizer
23.Table Products & Services of IntegraGen
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Liver Cancer Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Liver Cancer Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Liver Cancer Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Liver Cancer Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Liver Cancer Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Liver Cancer Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Liver Cancer Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Liver Cancer Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Liver Cancer Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Liver Cancer Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Liver Cancer Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Targeted Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Radiation Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Immunotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Chemotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Hepatocellular Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Cholangio Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Hepatoblastoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Targeted Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Radiation Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Immunotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Chemotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Hepatocellular Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Cholangio Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Hepatoblastoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Targeted Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Radiation Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Immunotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Chemotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Hepatocellular Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Cholangio Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49dZFkcrKdk7XegyMd3kp4MGQoLFeMWM6Lion2T3q3h6DScBViFrXXuZoxkHq1TB1mGufMoGzfXd7jJ7ocgpJGxdEiGirjGYOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Targeted Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Radiation Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Immunotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Chemotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Hepatocellular Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Cholangio Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Hepatoblastoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Targeted Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Radiation Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Immunotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Chemotherapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Hepatocellular Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Cholangio Carcinoma Segmentation Market Size (USD Million) 2017-2021f and Yea

Electronic files(PDF) of market research reports will be dispatched within 48-72 hours. (Mon-Fri IST)

Select License Type

Why Choose InForGrowth?
  • Customer Insights
  • Market Opportunity Mapping
  • Competitive Intelligence for Key Companies
  • Market Entry Strategy
  • Product Mix and Pricing
  • Segmentation Analysis
  • Benchmarking Research based on Ecosystem and Interconnectivity
  • Market Attractiveness Framework
  • Demand-Supply Scenario & Performance Optimization
  • Technology Landscape & Revenue Augmenting Plans
  • Impact of Circular Economy or Digital Transformation Trends
  • Region Specific Reports / Country Specific Reports for Specific Topics
  • As Per Customer Need Section Wise Reports
  • Subscription Service with Real-Time Updates
  • Access to all the Research Studies in the Chosen Domains/Verticals
  • Pre and Post-Sales Service and Support
Need Help?
+
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.